484 related articles for article (PubMed ID: 23354167)
1. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.
Chou J; Lin JH; Brenot A; Kim JW; Provot S; Werb Z
Nat Cell Biol; 2013 Feb; 15(2):201-13. PubMed ID: 23354167
[TBL] [Abstract][Full Text] [Related]
2. miR-29b moulds the tumour microenvironment to repress metastasis.
Melo SA; Kalluri R
Nat Cell Biol; 2013 Feb; 15(2):139-40. PubMed ID: 23377028
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
4. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis.
Dydensborg AB; Rose AA; Wilson BJ; Grote D; Paquet M; Giguère V; Siegel PM; Bouchard M
Oncogene; 2009 Jul; 28(29):2634-42. PubMed ID: 19483726
[TBL] [Abstract][Full Text] [Related]
5. GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3.
Li M; Qi Y; Chen M; Wang Z; Zeng D; Xiao Y; Li S; Lin H; Wei X; Zhang G
Int J Biol Sci; 2019; 15(12):2522-2537. PubMed ID: 31754326
[TBL] [Abstract][Full Text] [Related]
6. TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals.
Zhang K; Cai HX; Gao S; Yang GL; Deng HT; Xu GC; Han J; Zhang QZ; Li LY
Oncotarget; 2016 Oct; 7(43):69436-69449. PubMed ID: 27589684
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-720 suppresses M2 macrophage polarization by targeting GATA3.
Zhong Y; Yi C
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27354564
[TBL] [Abstract][Full Text] [Related]
8. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH
Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480
[TBL] [Abstract][Full Text] [Related]
9. GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.
Chu IM; Michalowski AM; Hoenerhoff M; Szauter KM; Luger D; Sato M; Flanders K; Oshima A; Csiszar K; Green JE
Oncogene; 2012 Apr; 31(16):2017-27. PubMed ID: 21892208
[TBL] [Abstract][Full Text] [Related]
10. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
11. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
Shahi P; Wang CY; Chou J; Hagerling C; Gonzalez Velozo H; Ruderisch A; Yu Y; Lai MD; Werb Z
Oncogene; 2017 Oct; 36(40):5567-5575. PubMed ID: 28581515
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression.
Fang JH; Zhou HC; Zeng C; Yang J; Liu Y; Huang X; Zhang JP; Guan XY; Zhuang SM
Hepatology; 2011 Nov; 54(5):1729-40. PubMed ID: 21793034
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
[TBL] [Abstract][Full Text] [Related]
15. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
Li JT; Jia LT; Liu NN; Zhu XS; Liu QQ; Wang XL; Yu F; Liu YL; Yang AG; Gao CF
Oncotarget; 2015 Oct; 6(31):30818-30. PubMed ID: 26360780
[TBL] [Abstract][Full Text] [Related]
17. EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
Yin H; Wang Y; Wu Y; Zhang X; Zhang X; Liu J; Wang T; Fan J; Sun J; Yang A; Zhang R
Theranostics; 2020; 10(19):8494-8512. PubMed ID: 32754259
[TBL] [Abstract][Full Text] [Related]
18. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-29b suppresses tumor growth through simultaneously inhibiting angiogenesis and tumorigenesis by targeting Akt3.
Li Y; Cai B; Shen L; Dong Y; Lu Q; Sun S; Liu S; Ma S; Ma PX; Chen J
Cancer Lett; 2017 Jul; 397():111-119. PubMed ID: 28365400
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.
Sereesongsaeng N; McDowell SH; Burrows JF; Scott CJ; Burden RE
Breast Cancer Res; 2020 Dec; 22(1):139. PubMed ID: 33298139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
